BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND SDHA, SDH2, 6389, ENSG00000073578, FP, P31040, SDHF
263 results:

  • 1. Nanoparticles targeting mutant p53 overcome chemoresistance and tumor recurrence in non-small cell lung cancer.
    Bi YY; Chen Q; Yang MY; Xing L; Jiang HL
    Nat Commun; 2024 Mar; 15(1):2759. PubMed ID: 38553451
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. ANGPT1 promotes M1 macrophage polarization and inhibits lung adenocarcinoma progression by inhibiting the TGF-β signalling pathway.
    Liu G; Zhang H
    Gen Physiol Biophys; 2024 Mar; 43(2):121-138. PubMed ID: 38477603
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Correlation of MRI quantitative perfusion parameters with EGFR, VEGF and EGFR gene mutations in non-small cell cancer.
    Zou M; Zhang B; Shi L; Mao H; Huang Y; Zhao Z
    Sci Rep; 2024 Feb; 14(1):4447. PubMed ID: 38396128
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. An in-silico analysis reveals further evidence of an aggressive subset of lung carcinoids sharing molecular features of high-grade neuroendocrine neoplasms.
    Pelosi G; Melocchi V; Dama E; Hofman P; De Luca M; Albini A; Gemelli M; Ricotta R; Papotti M; La Rosa S; Uccella S; Harari S; Sonzogni A; Asiedu MK; Wigle DA; Bianchi F
    Exp Mol Pathol; 2024 Feb; 135():104882. PubMed ID: 38237798
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer.
    Cho BC; Chiu CH; Massarelli E; Buchschacher GL; Goto K; Overbeck TR; Loong HHF; Chee CE; Garrido P; Dong X; Fan Y; Lu S; Schwemmers S; Bordogna W; Zeuner H; Osborne S; John T
    Lung Cancer; 2024 Feb; 188():107442. PubMed ID: 38171156
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Performance Analysis in Children of Traditional and Deep Learning CT lung Nodule Computer-Aided Detection Systems Trained on Adults.
    Hardie RC; Trout AT; Dillman JR; Narayanan BN; Tanimoto AA
    AJR Am J Roentgenol; 2024 Feb; 222(2):e2330345. PubMed ID: 37991333
    [No Abstract]    [Full Text] [Related]  

  • 7. HDAC5 modulates SATB1 transcriptional activity to promote lung adenocarcinoma.
    Sharma S; Tyagi W; Tamang R; Das S
    Br J Cancer; 2023 Sep; 129(4):586-600. PubMed ID: 37400677
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RNA sequencing reveals the transcriptomic landscape and alternative splicing events induced by LGALS1 silencing in non-small cell lung cancer.
    Shi H; Zhang Y; Liu J; Wang Y; Fang P
    Adv Clin Exp Med; 2024 Jan; 33(1):79-90. PubMed ID: 37341175
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Can incorrect artificial intelligence (AI) results impact radiologists, and if so, what can we do about it? A multi-reader pilot study of lung cancer detection with chest radiography.
    Bernstein MH; Atalay MK; Dibble EH; Maxwell AWP; Karam AR; Agarwal S; Ward RC; Healey TT; Baird GL
    Eur Radiol; 2023 Nov; 33(11):8263-8269. PubMed ID: 37266657
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proteins Secreted by lung cancer Cells Induce the Onset of Proteinuria via Focal Adhesion Kinase Signaling in Mice.
    Niu SW; Wu CH; Chen HC; Yang CJ; Chang JM; Chang EE; Chuang HH; Chiu YW; Zhen YY; Hung CC; Hwang SJ
    Lab Invest; 2023 Aug; 103(8):100156. PubMed ID: 37119854
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [A Case of Specific Pneumonia Diagnosed as Peritumoral Infiltration during Nivolumab Treatment for Esophageal cancer].
    Sasaki N; Miura A; Suzuki K; Haruki S; Yamaguchi K
    Gan To Kagaku Ryoho; 2023 Apr; 50(4):526-528. PubMed ID: 37066476
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Surgical phenotype of patients with peritoneal mesothelioma and a germline mutation.
    Berger Y; Gadiraju M; Dhiman A; Gilliam K; Opalecky B; Chen H; Helgeson M; Eng OS; Husain AN; Drazer MW; Kindler HL; Churpek JE; Turaga KK
    Cancer; 2023 Jul; 129(14):2152-2160. PubMed ID: 37042570
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery.
    Wang JY; Qu V; Hui C; Sandhu N; Mendoza MG; Panjwani N; Chang YC; Liang CH; Lu JT; Wang L; Kovalchuk N; Gensheimer MF; Soltys SG; Pollom EL
    Radiat Oncol; 2023 Apr; 18(1):61. PubMed ID: 37016416
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Can frailty scores predict the incidence of cancer? Results from two large population-based studies.
    Mak JKL; Kuja-Halkola R; Wang Y; Hägg S; Jylhävä J
    Geroscience; 2023 Jun; 45(3):2051-2064. PubMed ID: 36997701
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. New pathogenic germline variants identified in mesothelioma.
    Belcaid L; Bertelsen B; Wadt K; Tuxen I; Spanggaard I; Højgaard M; Benn Sørensen J; Ravn J; Lassen U; Cilius Nielsen F; Rohrberg K; Westmose Yde C
    Lung Cancer; 2023 May; 179():107172. PubMed ID: 36944283
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. ACADL suppresses PD-L1 expression to prevent cancer immune evasion by targeting Hippo/YAP signaling in lung adenocarcinoma.
    Li L; Wang LL; Wang TL; Zheng FM
    Med Oncol; 2023 Mar; 40(4):118. PubMed ID: 36929466
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A systematic review and meta-analysis of the diagnostic value of circulating microRNA-17-5p in patients with non-small cell lung cancer.
    Hao J; Shen Z
    Medicine (Baltimore); 2023 Feb; 102(8):e33070. PubMed ID: 36827064
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Frozen sections accurately predict the IASLC proposed grading system and prognosis in patients with invasive lung adenocarcinomas.
    Fan J; Yao J; Si H; Xie H; Ge T; Ye W; Chen J; Yin Z; Zhuang F; Xu L; Su H; Zhao S; Xie X; Zhao D; Wu C; Zhu Y; Ren Y; Xu N; Chen C;
    Lung Cancer; 2023 Apr; 178():123-130. PubMed ID: 36822017
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. An Efficient Model for lungs Nodule Classification Using Supervised Learning Technique.
    Eid Alazemi F; Jehangir B; Imran M; Song OY; Karamat T
    J Healthc Eng; 2023; 2023():8262741. PubMed ID: 36785839
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PSMA1, a Poor Prognostic Factor, Promotes Tumor Growth in lung Squamous Cell Carcinoma.
    Liu Z; Wang W; Zhou Y; Li L; Zhou W
    Dis Markers; 2023; 2023():5386635. PubMed ID: 36776923
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 14.